Kołodziejska Barbara, Kaflak Agnieszka, Kolmas Joanna
Chair of Analytical Chemistry and Biomaterials, Department of Analytical Chemistry, Medical University of Warsaw, ul. Banacha 1, 02-097 Warsaw, Poland.
Materials (Basel). 2020 Apr 9;13(7):1748. doi: 10.3390/ma13071748.
Type I collagen and nanocrystalline-substituted hydroxyapatite are the major components of a natural composite-bone tissue. Both of these materials also play a significant role in orthopedic surgery and implantology; however, their separate uses are limited; apatite is quite fragile, while collagen's mechanical strength is very poor. Therefore, in biomaterial engineering, a combination of collagen and hydroxyapatite is used, which provides good mechanical properties with high biocompatibility and osteoinduction. In addition, the porous structure of the composites enables their use not only as bone defect fillers, but also as a drug release system providing controlled release of drugs directly to the bone. This feature makes biomimetic collagen-apatite composites a subject of research in many scientific centers. The review focuses on summarizing studies on biological activity, tested in vitro and .
I型胶原蛋白和纳米晶取代羟基磷灰石是天然复合骨组织的主要成分。这两种材料在骨科手术和植入学中也发挥着重要作用;然而,它们单独使用时存在局限性;磷灰石相当脆弱,而胶原蛋白的机械强度很差。因此,在生物材料工程中,会使用胶原蛋白和羟基磷灰石的组合,这种组合具有良好的机械性能、高生物相容性和骨诱导性。此外,复合材料的多孔结构使其不仅可以用作骨缺损填充材料,还可以用作药物释放系统,能够将药物直接可控地释放到骨骼中。这一特性使仿生胶原蛋白-磷灰石复合材料成为许多科研中心的研究对象。本综述着重总结了在体外进行测试的关于生物活性的研究。